Springer Nature
Browse
12933_2022_1549_MOESM1_ESM.doc (94 kB)

Additional file 1 of The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study

Download (94 kB)
journal contribution
posted on 2022-06-29, 06:28 authored by Yi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, Hsin-Fu Lee, Pei-Ru Li, Wei-Min Chen, Yung-Hsin Yeh, Chi-Tai Kuo, Lai-Chu See, Gregory Y. H. Lip
Additional file 1: Table S1 International Classification of Diseases (10th edition) Clinical Modification (ICD 10-CM) codes used to define comorbidities and clinical outcomes in this study.

Funding

Ministry of Science and Technology Chang Gung Memorial Hospital

History

Usage metrics

    Cardiovascular Diabetology

    Categories

    Keywords

    Atrial fibrillationType 2 diabetes mellitusSodium-glucose cotransporter-2 inhibitorGlucagon-like peptide-1 receptor agonistDipeptidyl peptidase-4 inhibitor

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC